Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Strippoli · SciRah

Researcher profile · Semantic Scholar

A. Strippoli

Share profile

A. Strippoli — researcher profile on SciRah

h-index: 23
Works: 82
Citations: 1,524

Most-cited papers

Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.
E. Rinninella, M. Cintoni, P. Raoul, C. Pozzo +5 more
2019Clinical Nutrition132 citations
Semantic Scholar
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
S. Rossi, M. Basso, A. Strippoli, G. Schinzari +4 more
2017Clinical colorectal cancer119 citations
Semantic Scholar
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials.
E. Rinninella, M. Cintoni, P. Raoul, C. Pozzo +5 more
2020Clinical Nutrition ESPEN105 citations
Semantic Scholar
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
A. Inno, M. Di Salvatore, T. Cenci, M. Martini +7 more
2011Clinical colorectal cancer86 citations
Semantic Scholar
INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).
F. Pietrantonio, A. Raimondi, S. Lonardi, S. Murgioni +16 more
2023Journal of Clinical Oncology80 citations Open access
Semantic Scholar
Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.
S. Rossi, M. Basso, A. Strippoli, V. Dadduzio +6 more
2015Clinical Breast Cancer77 citations
Semantic Scholar
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
I. V. Zurlo, Mattia Schino, A. Strippoli, M. Calegari +11 more
2021Cancer Immunology and Immunotherapy70 citations Open access
Semantic Scholar
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors
A. Strippoli, A. Cocomazzi, M. Basso, T. Cenci +10 more
2020Cancers66 citations Open access
Semantic Scholar
Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
A. Di Giorgio, C. Schena, M. A. El Halabieh, C. Abatini +7 more
2020Surgical oncology57 citations
Semantic Scholar
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study
A. Raimondi, Federica Palermo, M. Prisciandaro, M. Aglietta +28 more
2021Cancers50 citations Open access
Semantic Scholar
Results of the observational prospective RealFLOT study
E. Giommoni, D. Lavacchi, G. Tirino, L. Fornaro +20 more
2021BMC Cancer43 citations Open access
Semantic Scholar
Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
S. Rossi, V. Di Noia, Laura Tonetti, A. Strippoli +6 more
2018Future Oncology40 citations
Semantic Scholar
The Role of Staging Laparoscopy for Gastric Cancer Patients: Current Evidence and Future Perspectives
C. Schena, V. Laterza, Davide De Sio, G. Quero +7 more
2023Cancers30 citations Open access
Semantic Scholar
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study
M. Muscaritoli, Alessandra Modena, M. Valerio, P. Marchetti +16 more
2023Cancers29 citations Open access
Semantic Scholar
Enhanced recovery after surgery (ERAS) versus standard recovery for gastric cancer patients: The evidences and the issues.
F. Rosa, F. Longo, C. Pozzo, A. Strippoli +4 more
2022Surgical oncology29 citations
Semantic Scholar
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
M. Basso, A. Strippoli, A. Orlandi, M. Martini +7 more
2012British Journal of Cancer29 citations Open access
Semantic Scholar
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study
F. Nappo, L. Fornaro, L. Pompella, S. Catanese +19 more
2023Journal of Cancer Research and Clinical Oncology28 citations Open access
Semantic Scholar
Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study
E. Rinninella, A. Strippoli, M. Cintoni, P. Raoul +9 more
2021Nutrients26 citations Open access
Semantic Scholar
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges
E. Rinninella, M. Cintoni, P. Raoul, C. Pozzo +7 more
2020Nutrients26 citations Open access
Semantic Scholar
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis
S. Rossi, E. D'Argento, M. Basso, A. Strippoli +5 more
2015Molecular Diagnosis & Therapy26 citations
Semantic Scholar
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis
E. Rinninella, M. Cintoni, P. Raoul, F. Ponziani +7 more
2020Internal and Emergency Medicine25 citations Open access
Semantic Scholar
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases
M. Basso, V. Dadduzio, F. Ardito, P. Lombardi +8 more
2016Medicine24 citations Open access
Semantic Scholar
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.
S. Rossi, G. Schinzari, M. Basso, A. Strippoli +4 more
2016Future Oncology23 citations
Semantic Scholar
The Role of Surgery in the Management of Gastric Cancer: State of the Art
F. Rosa, C. Schena, V. Laterza, G. Quero +5 more
2022Cancers20 citations Open access
Semantic Scholar
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas
Armando Orlandi, M. Di Salvatore, C. Bagalà, M. Basso +6 more
2015Journal of Cancer20 citations Open access
Semantic Scholar
Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?
I. V. Zurlo, M. Basso, A. Strippoli, M. Calegari +8 more
2020Cancers19 citations Open access
Semantic Scholar
Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
S. Corallo, E. D'Argento, A. Strippoli, M. Basso +4 more
2017Targeted oncology19 citations
Semantic Scholar
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all.
A. Biondi, A. Agnes, Federica Del Coco, C. Pozzo +3 more
2018Surgical oncology18 citations
Semantic Scholar
Liquid biopsy to predict benefit from rechallenge with cetuximab (cet) + irinotecan (iri) in RAS/BRAF wild-type metastatic colorectal cancer patients (pts) with acquired resistance to first-line cet+iri: Final results and translational analyses of the CRICKET study by GONO.
D. Rossini, C. Cremolini, E. Conca, M. Del Re +16 more
201817 citations
Semantic Scholar
First-line Treatment of Advanced Biliary Ducts Carcinoma: A Randomized Phase II Study Evaluating 5-FU/LV Plus Oxaliplatin (Folfox 4) Versus 5-FU/LV (de Gramont Regimen).
G. Schinzari, E. Rossi, Giuseppina Mambella, A. Strippoli +5 more
2017Anticancer Research17 citations Open access
Semantic Scholar
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis
A. Strippoli, S. Rossi, M. Martini, M. Basso +5 more
2016OncoTarget17 citations Open access
Semantic Scholar
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis
M. Di Salvatore, L. Giudice, E. Rossi, C. Santonocito +11 more
2015Clinical and Translational Oncology15 citations
Semantic Scholar
Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments
F. Santullo, F. Ferracci, C. Abatini, M. A. El Halabieh +8 more
2023Langenbeck's archives of surgery (Print)13 citations
Semantic Scholar
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer
A. Agnes, A. Biondi, A. Laurino, A. Strippoli +4 more
2020Journal of Surgical Oncology13 citations
Semantic Scholar
Gastrointestinal stromal tumors (GISTs) and second malignancies
M. Rodriquenz, S. Rossi, R. Ricci, M. Martini +9 more
2016Medicine12 citations Open access
Semantic Scholar
Liquid biopsy allows predicting benefit from rechallenge with cetuximab(cet)+irinotecan(iri) in RAS/BRAF wild-type mCRC patients(pts) with resistance to 1st-line cet+iri: Final results and translational analyses of the CRICKET study by GONO.
D. Rossini, C. Cremolini, E. Conca, M. Del Re +16 more
2018Annals of Oncology11 citations Open access
Semantic Scholar
Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies
S. Rossi, A. Cassano, A. Strippoli, G. Schinzari +3 more
2017Drugs in Context11 citations Open access
Semantic Scholar
DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.
V. Di Noia, M. Basso, V. Marsico, Eleonora Cerchiaro +7 more
2019Future Oncology10 citations
Semantic Scholar
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases
M. Basso, S. Corallo, M. Calegari, I. V. Zurlo +15 more
2020Scientific Reports8 citations Open access
Semantic Scholar
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study
V. Dadduzio, M. Basso, S. Rossi, T. Cenci +8 more
2015Molecular Diagnosis & Therapy7 citations
Semantic Scholar
Safety and Efficacy of a First-Line Chemotherapy Tailored by G8 Score in Elderly Metastatic or Locally Advanced Gastric and Gastro-Esophageal Cancer Patients: A Real-World Analysis
I. V. Zurlo, C. Pozzo, A. Strippoli, S. Mignogna +8 more
2022Geriatrics6 citations Open access
Semantic Scholar
Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really “Raising the Bar?”
V. Di Noia, E. Vita, M. Ferrara, A. Strippoli +6 more
2019Current Treatment Options in Oncology6 citations
Semantic Scholar
Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium
G. Schinzari, E. Rossi, F. Pierconti, G. Garufi +5 more
2015OncoTarget6 citations Open access
Semantic Scholar
ERCC1, KRAS mutation, and oxaliplatin sensitivity in colorectal cancer: Old dogs and new tricks.
A. Orlandi, M. Di Salvatore, M. Basso, C. Bagalà +8 more
2012Journal of Clinical Oncology6 citations
Semantic Scholar
Ramucirumab plus paclitaxel as switch maintenance versus continuation of oxaliplatin-based chemotherapy in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction (GEJ) cancer: The ARMANI phase III trial.
F. Pietrantonio, G. Randon, S. Lonardi, S. Garattini +16 more
2024Journal of Clinical Oncology5 citations
Semantic Scholar
Unexpected side effect in mCRC
M. Quirino, S. Rossi, G. Schinzari, M. Basso +3 more
2017Medicine4 citations Open access
Semantic Scholar
Bidirectional Systemic Chemotherapy and Pressurized Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis from Gastric Cancer
A. Di Giorgio, Stefano Rotolo, C. Abatini, M. A. El Halabieh +5 more
20203 citations
Semantic Scholar
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?
E. D'Argento, S. Rossi, G. Schinzari, A. Strippoli +3 more
2016Current Treatment Options in Oncology3 citations
Semantic Scholar
c-Myc expression as a key-marker in the colorectal cancer resistance to EGFR inhibitors.
M. Martini, M. Basso, A. Cocomazzi, T. Cenci +6 more
20163 citations
Semantic Scholar
The psychological projective test Wartegg-Zeichentest: A contribution to the knowledge of patients with cancer.
C. M. La Spina, C. Murasecchi, Sergio G. Stinco, A. Cassano +6 more
20103 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Cassano×28
Invite
A. Cassano — researcher profile on SciRah
C. Barone×27
Invite
C. Barone — researcher profile on SciRah
M. Basso×25
Invite
M. Basso — researcher profile on SciRah
G. Schinzari×15
Invite
G. Schinzari — researcher profile on SciRah

×14

Invite

S. Rossi — researcher profile on SciRah

Invite

C. Pozzo — researcher profile on SciRah

E. D'Argento×13

Invite

E. D'Argento — researcher profile on SciRah

Invite

E. Bria — researcher profile on SciRah

Invite

G. Tortora — researcher profile on SciRah

M. Di Salvatore×9

Invite

M. Di Salvatore — researcher profile on SciRah

Invite

M. Martini — researcher profile on SciRah

Invite

A. Orlandi — researcher profile on SciRah